Cargando…

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products

BACKGROUND: Clinical CAR T-cell therapy using integrating vector systems represents a promising approach for the treatment of hematological malignancies. Lentiviral and γ-retroviral vectors are the most commonly used vectors in the manufacturing process. However, the integration pattern of these vir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shao, Lipei, Shi, Rongye, Zhao, Yingdong, Liu, Hui, Lu, Alexander, Ma, Jinxia, Cai, Yihua, Fuksenko, Tatyana, Pelayo, Alejandra, Shah, Nirali N., Kochenderfer, James N., Norberg, Scott M., Hinrichs, Christian, Highfill, Steven L., Somerville, Robert P, Panch, Sandhya R., Jin, Ping, Stroncek, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644589/ https://www.ncbi.nlm.nih.gov/pubmed/36348415 http://dx.doi.org/10.1186/s12967-022-03729-5

Ejemplares similares

Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays
por: Ma, Jinxia, et al.
Publicado: (2023)

Identification of genomic signatures in bone marrow associated with clinical response of CD19 CAR T-cell therapy
por: Shao, Lipei, et al.
Publicado: (2022)

Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases
por: Shao, Lipei, et al.
Publicado: (2022)

Application of droplet digital PCR for the detection of vector copy number in clinical CAR/TCR T cell products
por: Lu, Alex, et al.
Publicado: (2020)

Cryopreserved anti-CD22 and bispecific anti-CD19/22 CAR T cells are as effective as freshly infused cells
por: Dreyzin, Alexandra, et al.
Publicado: (2022)

Establishment and validation of in-house cryopreserved CAR/TCR-T cell flow cytometry quality control
por: Cai, Yihua, et al.
Publicado: (2021)

Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulation
por: Holland, Elizabeth M, et al.
Publicado: (2022)

High efficiency closed-system gene transfer using automated spinoculation
por: Remley, Victoria Ann, et al.
Publicado: (2021)

The need for uniform and coordinated practices involving centrally manufactured cell therapies
por: Stroncek, David, et al.
Publicado: (2022)

Point-of-care cell therapy manufacturing; it’s not for everyone
por: Stroncek, David F., et al.
Publicado: (2022)

Single cell sequencing reveals gene expression signatures associated with bone marrow stromal cell subpopulations and time in culture
por: Liu, Shutong, et al.
Publicado: (2019)

Il-6 is non-essential to murine CD19 CAR efficacy, but can mediate acute GVHD following allogeneic BMT with CAR T cell infusion
por: Jacoby, Elad, et al.
Publicado: (2015)

Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument
por: Panch, Sandhya R., et al.
Publicado: (2019)

Longitudinal Transcriptional Analysis of Peripheral Blood Leukocytes in COVID Convalescent Donors
por: Gedda, Mallikarjuna Rao, et al.
Publicado: (2021)

Long-term outcomes following CAR T cell therapy: what we know so far
por: Cappell, Kathryn M., et al.
Publicado: (2023)

Longitudinal transcriptional analysis of peripheral blood leukocytes in COVID-19 convalescent donors
por: Gedda, Mallikarjuna R., et al.
Publicado: (2022)

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes
por: Faruqi, Aiman J., et al.
Publicado: (2022)

Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
por: Stroncek, David F., et al.
Publicado: (2017)

CD70 CAR T cells in AML: Form follows function
por: Mirazee, Justin, et al.
Publicado: (2022)

Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
por: Jin, Jianjian, et al.
Publicado: (2018)

Mediport use as an acceptable standard for CAR T cell infusion
por: Eylon, Maya, et al.
Publicado: (2023)

How I treat refractory CRS and ICANS after CAR T-cell therapy
por: Jain, Michael D., et al.
Publicado: (2023)

CD22-CAR T Cells Induce Remissions in CD19-CAR Naïve and Resistant B-ALL
por: Fry, Terry J., et al.
Publicado: (2017)

IL-12-conditioning improves retrovirally-mediated transduction efficiency of CD8(+) T cells
por: Andrijauskaite, Kristina, et al.
Publicado: (2015)

Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
por: Katz, Steven, et al.
Publicado: (2016)

Safety and feasibility of anti-CD19 CAR T cells with fully-human binding domains in patients with B-cell lymphoma
por: Brudno, Jennifer N., et al.
Publicado: (2020)

Efficient clinical-grade γ-retroviral vector purification by high-speed centrifugation for CAR T cell manufacturing
por: Mekkaoui, Leila, et al.
Publicado: (2022)

Retroviral DNA Integration
por: Lesbats, Paul, et al.
Publicado: (2016)

CAR T-cell detection scoping review: an essential biomarker in critical need of standardization
por: Turicek, David P, et al.
Publicado: (2023)

High-Definition Mapping of Retroviral Integration Sites Defines the Fate of Allogeneic T Cells After Donor Lymphocyte Infusion
por: Cattoglio, Claudia, et al.
Publicado: (2010)

CAR(+) and CAR(−) T cells share a differentiation trajectory into an NK-like subset after CD19 CAR T cell infusion in patients with B cell malignancies
por: Louie, Raymond Hall Yip, et al.
Publicado: (2023)

Retroviral proteases
por: Dunn, Ben M, et al.
Publicado: (2002)

P1380: THE COMPOSITION OF INFUSED CD19-CAR-T PRODUCT IMPACTS ON EFFICACY
por: Bellesi, Silvia, et al.
Publicado: (2023)

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions
por: Lam, Norris, et al.
Publicado: (2023)

Is Sjögren's syndrome a retroviral disease?
por: Sipsas, Nikolaos V, et al.
Publicado: (2011)

Matrix attachment regions as targets for retroviral integration
por: Johnson, Chassidy N, et al.
Publicado: (2005)

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
por: Boyiadzis, Michael M., et al.
Publicado: (2018)

Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR‐T cell infusion
por: Geerts, Paulus A. F., et al.
Publicado: (2023)

The sense behind retroviral anti-sense transcription
por: Manghera, Mamneet, et al.
Publicado: (2017)

Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
por: Diorio, Caroline, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dfubmftt677drvo6es7ulcgqqk